1-6 of 6
James E. Talmadge, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunologic and Clinical Responses To a CD20-Targeted Immunocytokine, DI-Leu16-IL2, In Relapsed Non-Hodgkin Lymphoma

Ryotaro Nakamura, Robert Chen, MD, Joycelynne Palmer, PhD, Karl Gaal, MD, Auayporn Nademanee, MD, Leslie Popplewell, MD, James E. Talmadge, PhD, Stephen Gillies, PhD, David Colcher, PhD, Stephen J. Forman, MD, Andrew Raubitschek, MD
Journal: Blood
Blood (2013) 122 (21): 1808.
https://doi.org/10.1182/blood.V122.21.1808.1808
Published: 2013
Journal Articles

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

James E. Talmadge, PhD, Ugur Coskun, PhD, Sarah Maas, MS, Orhan Turken, MD, Ziviko S. Pavletic, MD, Charles A. Kuszynski, PhD, Marcel Devetten, MD, Laura R. Schafer, MS, Lori Zobel, BS, Robert G. Bociek, MD
Journal: Blood
Blood (2007) 110 (11): 2994.
https://doi.org/10.1182/blood.V110.11.2994.2994
Published: 2007
Journal Articles

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products.

Dumrul Gulen, PhD, Robert G. Bociek, MD, Ugur Coskun, MD, Marcel P. Devetten, MD, James E. Talmadge, PhD
Journal: Blood
Blood (2006) 108 (11): 5176.
https://doi.org/10.1182/blood.V108.11.5176.5176
Published: 2006
Journal Articles

Differential T Cell Suppression by Two Different Pentostatin Conditioning Protocols for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Ugur Coskun, MD, Robert G. Bociek, MD, Zivko S. Pavletic, MD, Charlie Kuszynski, PhD, Marcel Devetten, MD, Laura Shafer, Lori Zobel, James E. Talmadge, PhD
Journal: Blood
Blood (2006) 108 (11): 5373.
https://doi.org/10.1182/blood.V108.11.5373.5373
Published: 2006
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

R. Gregory Bociek, MD, MSc, James E. Talmadge, PhD, James C. Lynch, PhD, Charles A. Enke, MD, Charles A. Kuszynski, PhD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Timothy R. McGuire, PhD, James L. Wisecarver, MD, Shantaram S. Joshi, PhD, Zivko S. Pavletic, MD
Journal: Blood
Blood (2005) 106 (11): 3671.
https://doi.org/10.1182/blood.V106.11.3671.3671
Published: 2005
Journal Articles

Intratumoral, Injection of Adenoviral Flt3 Ligand Has Therapeutic Activity in Association with Increased Intratumoral Levels of T Cells but Not Dendritic Cells.

James E. Talmadge, PhD, Scott G. Kurz, MSc, Randy R. Fields, BS, Devendra K. Agrawal, PhD, Rakesh K. Singh, PhD, Drake M. LaFace, PhD, Abdel-kader E. Ashour, PhD, Lora R. Shafer, BS, Joyce E. Solhwim, PhD
Journal: Blood
Blood (2004) 104 (11): 5280.
https://doi.org/10.1182/blood.V104.11.5280.5280
Published: 2004